v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net loss $ (21,730,232) $ (21,150,211)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 679,648 839,242
Stock-based compensation expense 688,050 1,956,078
Common stock issued for financial advisory services 135,000
Change in fair value of acquisition contingencies (106,464) (684,944)
Non-cash lease expense 3,411 (4,985)
Realized gain on investments (683,365)
Loss from equity method investment 165,554 71,163
Loss on disposition of assets 5,004
Provision for (recoveries of) credit losses 2,053 (22,375)
Inventory obsolescence recoveries (65,858) (138,983)
Changes in assets and liabilities:    
Accounts receivable 136,494 99,040
Prepaid expenses and other assets 127,570 (69,584)
Inventory 385,305 121,752
Deferred revenue (12,800) 4,700
Income taxes payable (221,795)
Accounts payable, accrued expenses and other liabilities (956,032) (3,193,366)
Net cash used in operating activities (20,683,301) (22,937,629)
Cash flows from investing activities    
Purchases of property and equipment (175,299) (568,078)
Proceeds from maturities of marketable investment securities 33,761,847
Purchases of marketable securities (6,590,939)
Investment in joint ventures (150,000)
Net cash (used in) provided by investing activities (325,299) 26,602,830
Cash flows from financing activities    
Issuance of common stock related to private placement transaction and warrant exercises, net of offering costs 5,177,214
Issuance of common stock related to at-the-market offering, net of offering costs 4,661,582 1,313,929
Issuance of common stock related to registered direct offering, net of offering costs 3,528,269
Net cash provided by financing activities 9,838,796 4,842,198
Net increase (decrease) in cash and cash equivalents (11,169,804) 8,507,399
Cash and cash equivalents at beginning of period 11,884,607 2,936,544
Cash and cash equivalents at end of period 714,803 11,443,943
Supplemental disclosure of cash flow information    
Cash received for income taxes 26,592 1,656
Supplemental disclosure of non-cash investing and financing transactions    
Right-of-use assets obtained in exchange for new operating lease liabilities $ 1,029,215